After much controversy regarding the quality of stents manufactured in India, yet another study comparing an Indian stent with the foremost foreign stent brand has concluded it is just as good. At the scientific session of the American Heart Association in Chicago, cardiologists from Germany presented the results of an extended follow up of 2,603 patients. The patients were randomized to treatment with two new generation stents everolimus and sirolimus, and a first generation sirolimus.
The results of a 10-year study comparing clinical outcomes of the Indian stent with those of the stents from the American company, showed that they were equally good. A study presented two months back had also concluded that another Indian stent, was as good as foreign stent. In February 2017, the government had capped the price of stents leading to a three-fourths reduction in the prices for drug…
